莫尔塔林和PINK1/帕金介导的线粒是药物开发的卵巢癌选择性标
Vishal Chandra1, Justin Garland2, Rajani Rai1
1Gynecologic Oncology Section, Stephenson Cancer Center, Obstetrics and Gynecology Department, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|July 21, 2025
概括
新型药物SHetA2针对mortalin,一种在卵巢癌中增加的必需蛋白质进口伴侣. 在临床前模型中,SHetA2通过破坏死亡蛋白相互作用和诱导线粒,选择性地杀死癌细胞,改善了临床前模型中的存活率.
科学领域:
- 线粒体生物学 线粒体生物学
- 癌细胞生物学 癌细胞生物学
- 药物发现 药物发现
背景情况:
- 莫尔塔林是一种对蛋白质进口至关重要的线粒体伴侣,在卵巢癌中经常过度表达,与预后不佳相关.
- 实验药物SHetA2与mortalin相互作用,可能释放其客户端蛋白质并影响细胞过程.
研究的目的:
- 为了研究SHetA2和mortalin之间的分子相互作用.
- 阐明卵巢癌与非癌细胞对SHetA2治疗的独特细胞和分子反应.
- 在卵巢癌模型中评估SHetA2的治疗潜力.
主要方法:
- 表面等离子体共振 (SPR) 和核磁共振 (NMR) 来研究SHetA2-mortalin相互作用.
- 细胞检测评估线粒体功能,水平,自和线粒体自.
- 在使用卵巢癌异种移植的体内研究.
主要成果:
- 在低微分子度下,SHetA2直接与mortalin的基质结合域结合,选择性地杀死癌细胞.
- 在这两种细胞类型中,SHetA2 破坏了死亡素进口,死亡素/异位素1,4,5-三酸盐受体复合体和氧化酸化.
- 在癌细胞中观察到的明显效应包括减少,改变线粒体动力学和诱导线粒体衰变,而非癌细胞显示线粒体分支增加和抗性自.
- SHetA2 抑制瘤生长,改善卵巢癌移植患者的存活率.
结论:
- SHetA2直接与mortalin的SBD结合,导致卵巢癌和非癌细胞的不同细胞反应.
- SHetA2对卵巢癌细胞表现出选择性细胞毒性,主要通过诱导髓.
- SHetA2作为治疗卵巢癌的治疗剂显示出希望,这需要进一步的临床研究.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:46Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
01:31The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
02:15M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K